Certain antirheumatic drugs reduce risk of diabetes, study says

06/21/2011 | HealthDay News

Patients with rheumatoid arthritis or psoriasis who took tumor necrosis factor inhibitors were 38% less likely to develop type 2 diabetes over 12 years, while those who took methotrexate and hydroxychloroquine were 23% and 46% less likely, respectively, to develop the disease compared with those who took other disease-modifying antirheumatic drugs, according to a study in the Journal of the American Medical Association. The researcher noted that the study was observational and did not demonstrate causality.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ